Home › Blood Cancers › NCT04806295
The Leukemia and Lymphoma Society (LLS) National Research Registry
RecruitingObservational study
Who can join
Ages 21 and older · All sexes
Full eligibility criteria
Inclusion Criteria: People with blood cancer, before, during, and after blood cancer treatments. Exclusion Criteria: People unable or unwilling to sign informed consent.
About the study
The Leukemia and Lymphoma Society (LLS) has built a National Research Registry to evaluate real world experiences and medical outcomes for people with blood cancer, before, during, and after blood cancer treatments.
What is being tested
- any/all treatments for blood cancer (other)
Sponsor: Blood Cancer United · Participants: 1,000 · Started: Jul 24, 2017
Contact the study team
- Larry Saltzman, MD · Phone: 844-696-7228
- Brian J Chadwick, BS RN · Phone: 9144145788
Official record on ClinicalTrials.gov — NCT04806295
Locations in the U.S.
| New York | Lymphoma and Leukemia Society, Rye Brook |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.